43 matches found.
RED, 8>1>3, Malignancy, Non-proprietary, Methotrexate 10mg tablets, Click here
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14183
RED, 10>1>3, Malignancy, immuno- suppression, Metoject®, Methotrexate pre-filled syringe, Click here
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14383
Golimumab, Simponi®, Methotrexate naive patients with Rheumatoid Arthritis (NICE TA224), Black traffic light, BLACK, Click here
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14322
Non-proprietary, Malignancy, immuno- suppression, Methotrexate 2.5mg tablets, 8>1>3, AMBER shared care, Red for 10mg tabs & injection, Click here
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=13873
Click here, Once weekly dosing, RED, Appendix 6, Malignant disease, rheumatic disease, UNLICENSED SPECIAL, Methotrexate liquid
URL: /elmmb-formulary/joint-medicines-formulary/index-search/?EntryId14=14004
10.0 Musculoskeletal and joint diseases
Last Modified: 07/02/2020
10.1.3 Drugs which suppress the rheumatic disease process
Last Modified: 14/03/2019
13.0 Skin
Last Modified: 07/01/2021
8.0 Malignant Disease and Immunosuppression
Last Modified: 30/11/2020
Black Traffic Light Drugs (Not Recommended for Use)
Last Modified: 11/01/2021
NPSA Methotrexate Patient Briefing.pdf
Last Modified: 21/06/2016
Last Modified: 26/05/2016
